A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia) (opens in a new tab)
Active, not recruiting
$2,715 in research paymentsLymphoma, B-Cell, Marginal ZoneLymphoma, Mantle-CellLOXO-305
Dr. Linda A. Danieu, MD
NPI1285614461
- Clinical trials
- 2
- Industry payments
- $182,948
- State license
- 1
- Year NPI issued
- 2006
- Practice address
- NJ
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Danieu's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Linda A. Danieu is a hematologist and oncologist in New Jersey
Dr. Danieu practices in New Jersey.
Dr. Danieu's NPI, 1285614461, was assigned on January 23, 2006. Dr. Danieu holds New Jersey license 25MA04611200.
NPI and contact details
- NPI
- 1285614461NPI Registry (opens in a new tab)
- NPI enumeration date
- January 23, 2006
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dmand AI tracks the EHR system at Dr. Linda A. Danieu's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Danieu practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Danieu's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Danieu practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Linda A. Danieu is one of 364 hematologists and oncologists in New Jersey
Hematology and oncology is Dr. Danieu's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Danieu is licensed in New Jersey.
Specialties and state licenses
- Hematology and oncology, New JerseyPrimary
Hematologists and oncologists near Dr. Danieu
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Linda A. Danieu has worked on 2 clinical trials
Dmand AI links Dr. Danieu to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Carcinoma, Medullary, Lymphoma, B-Cell, Marginal Zone and Carcinoma, Neuroendocrine. Open Payments lists research payments to Dr. Danieu that name 3 trials.
Conditions in Dr. Danieu's trials
- Carcinoma, Medullary
- Lymphoma, B-Cell, Marginal Zone
- Carcinoma, Neuroendocrine
- Lymphoma, Mantle-Cell
Investigators on the most trials with Dr. Danieu
Recent clinical trials with Dr. Danieu
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer (opens in a new tab)
Active, not recruiting
$2,175 in research paymentsCarcinoma, MedullaryCarcinoma, NeuroendocrineSelpercatinibCabozantinibVandetanib
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Linda A. Danieu received $182,948 in industry payments from 2017 to 2024
CMS Open Payments shows 95 general payments to Dr. Danieu from 2 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $138,585. It also lists 18 research payments totaling $193,575 from 2019 to 2025, naming 3 clinical trials.
General payments to Dr. Danieu by program year, 2017 to 2024
Companies that paid Dr. Danieu the most, 2017 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Linda A. Danieu's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Linda A. Danieu
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Linda A. Danieu's NPI number?
Dr. Linda A. Danieu's NPI number is 1285614461. It was assigned on January 23, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Linda A. Danieu?
Dr. Linda A. Danieu is a hematologist and oncologist in New Jersey. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
What is Dr. Linda A. Danieu's medical license number?
Dr. Danieu holds New Jersey license 25MA04611200.
Has Dr. Linda A. Danieu received payments from drug or device companies?
CMS Open Payments shows $182,948 in general payments to Dr. Danieu from 2 companies from 2017 to 2024. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Linda A. Danieu been practicing?
Dr. Danieu's NPI was assigned in 2006.
Does Dr. Linda A. Danieu do research?
Dr. Danieu has worked on 2 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in New Jersey by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card